🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
AMB-053-01 is a randomized, placebo controlled, multicenter study which wil...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-03
Trial ID
NCT05349760
AMB-051-07 is an open-label, adaptive, dose-ranging study with long-term ex...
Status
Completed
Location
AmMax Bio, Clinical Site
Start Date
2023-01-26
Trial ID
NCT05349643
Treatments Being Tested
The purpose of this Phase 2, open-label, multiple-dose, dose-escalation stu...
Status
Terminated
Location
AmMax Bio Clinical Site
Start Date
2021-09-16
Trial ID
NCT04938180
Treatments Being Tested
To investigate the efficacy of AMB-05X in patients with CRC with MRD as det...
Status
Recruiting
Location
The University of Texas MD Anderson Cancer Center
Start Date
2024-12-04
Trial ID
NCT06617858
Treatments Being Tested
AMB-051-01 is a multicenter study with an adaptive design that will enroll ...
Status
Completed
Location
AmMax Bio Clinical Site
Start Date
2021-05-25
Trial ID
NCT04731675
Treatments Being Tested